Single-blind, randomized, controlled phase I/II study to compare the safety and immunogenicity of an inactivated influenza vaccine (whole virion, vero cell derived) with a license egg derived influenza vaccine
Phase of Trial: Phase I/II
Latest Information Update: 31 May 2018
At a glance
- Drugs Influenza A vaccine H5N1-Baxter (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Baxter BioScience; Baxter Healthcare Corporation
- 16 Oct 2007 Status changed from in progress to completed.
- 18 Nov 2006 New trial record.